2ISO K, TADA H, KUBOKI K, et al. Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in type 2 diabetic patients [ J ]. Journal of Diabetes and Its Complications, 2001,15 : 241 - 244.
3CRAVEN P, DERUBERTIS F. Sorbinil suppresses glomerular prostag|andin production in the strptozotocin diabetic rat [ J ]. Metabolism, 1989,38:649 - 654.
4PRAGA M. Therapeutic measures in proteinuric nephropathy [J]. Kidney Int,2005,68 : 137 - 141.
5VIVIAN E M, RUBINSTEIN G B. Pharmacologic management of diabetic nephropathy[J].Clinical Therapeutics ,2002,24( 11 ) : 1741 - 1755.
6ISHII H,TADA H ,ISOGAI S. An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells [ J ]. Diabetologia, 1998,41 : 362 - 364.
7PHILLIPS A, STEADMAN R, MORRISEY K,et al. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type Ⅳ collagen and fibronectin by decreased degradation [ J ]. Kidney Int, 1997,52 : 973 - 984.
8AIberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and clas- sification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998,15 (7) : 539-553.
9Tsugawa T, Shinohara B, Nagasaka A, et al. Alteration of urinary sorbitol excretion in WBN-kob diabetic rats-treatment with an aldose reductase inhibitor. J Endocrinol,2004,181 (3) :429-435.
10Huang P,Zhang Y, Jiang T, et al. Aldo~e reductase is a potent reg- Mator of TGFβ-induced expression of fibronectin in human mesangial cells. Mol Biol Rep,2010, 37(7) :3097-3103.
6Orchard TJ,Chang YF,Ferrell RE,et al.Nephropathy in type 1 diabetes:a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study[J].Kidney Int,2002,62 (3):963-970.
7Mykkǎnen L,Zaccaro DJ,Wagenknecht LE,et al.Microalbuminuria is associated with insulin resistance in nondiabetic subjects:the insulin resistance atherosclerosis study[J].Diabetes,1998,47 (5):793-800.
8Cho BH,Yu H,Kim KW,et al.Application of irregular and unbalanced data to predict diabetic nephropathy using visualization and feature selection methods[J].Artif Intell Med,2008,42 (1):37-53.
9Hsieh MC,Tien K J,Perng DS,et al.Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus[J].Metabolism,2009,58(4):504-509.
10Kim DM,Ahn CW,Park JS,et al.An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese,normal weight patients with type 2 diabetes mellitus in Korea[J].Diabetes Res Clin Pract,2004,66 Suppl 1:S169-172.
